Substance Name: Tocilizumab [USAN:INN]
RN: 375823-41-9
UNII: I031V2H011
Notes
- A humanised anti-interleukin-6 receptor monoclonal antibody,
- A humanised anti-interleukin-6 receptor monoclonal antibody.
Molecular Formula
- Unspecified
Classification Codes
- Antiviral (COVID-19)
- Treatment of Castelman's Disease
- Treatment of Crohn's Disease
- Treatment of Multiple Myeloma
- Treatment of Rheumatoid Arthritis
- Treatment of Systemic Juvenile Idiopathic Arthritis
- Treatment of Systemic Lupus Erythematosus
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Tocilizumab
- Tocilizumab [USAN:INN]
Synonyms
- Actemra
- Atlizumab
- Immunoglobulin G1, anti-(human interleukin 6 receptor) (human-mouse monoclonal MRA heavy chain), disulfide with human-mouse monoclonal MRA kappa-chain, dimmer. Molecular weight is approximately 144,986 daltons
- Monoclonal antibody, MRA
- MRA
- MSB-11456
- MSB11456
- R 1569
- R-1569
- RG-1569
- RHPM-1
- RO-4877533
- RoActemra
- RoActemra/Actemra
- Tocilizumab
- UNII-I031V2H011
Systematic Name
- Immunoglobulin G1, anti-(human interleukin 6 receptor) (human-mouse monoclonal MRA heavy chain), disulfide with human-mouse monoclonal MRA kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 375823-41-9
FDA UNII
- I031V2H011
System Generated Number
- 0375823419